Molecular mechanisms driving Aspergillus fumigatus disease: host interaction, virulence, biofilms, and resistance.

INTRODUCTION

Aspergillus fumigatus is a prevalent fungus that poses significant health dangers, especially for people with weakened immune systems. It may result in multiple conditions, such as allergic reactions, chronic pulmonary aspergillosis, and invasive aspergillosis, mainly impacting individuals with chronic lung diseases.

AIMS AND

OBJECTIVES

The main goals of this review article are to grasp the recent advancements in the knowledge of cellular and molecular mechanisms related to A. fumigatus pathogenesis, create enhanced diagnostic methods, and assess current therapies.

METHODS

This review emphasizes the importance of biofilms in maintaining infections and enhancing antifungal resistance. Human infections due to A. fumigatus offer chances for further investigation, and these developing research topics are examined. Progress in diagnosis and treatment includes the creation of novel antifungal medications, customized medical strategies, and innovative diagnostic technologies. The relationships between the host and fungi, as well as the pathophysiology, must be understood.

RESULTS

The virulence factors produced during A. fumigatus pathogenesis can harm respiratory epithelial cells and impair immune function. It can survive and grow at temperatures up to 50 °C and release toxic materials that can harm human tissues and weaken the immune system. Public health initiatives and environmental stewardship are examples of preventive strategies. The development of vaccines can safeguard groups at high risk.

CONCLUSION

Research on A. fumigatus pathogenesis reveals complex interactions between fungus and host cells. Aspergillus fumigatus is a global concern, with resistance rates increasing in Asia. New antifungal medicines, lipopeptides, and marine bioactive substances are being investigated to combat infections and improve health.